Breast cancer with lymph node metastases were in general associated with lower levels of the CSC genes ALDH1A3 and CD44, pluripotency markers POU5F1 and NEAT1, EMT marker SLUG, and drug resistance associated gene ERBB2, after DOX treatment. The gene discussed is ERBB2; the disease is breast carcinoma.